Trial site
Wollongong Hospital
- 30running trials
- 10closed trials
The trials here
What the 40 trials at this site are about, from their registry records.
- Conditions
- Multiple myeloma6 trials
- Prostate cancer5 trials
- Coronary artery disease4 trials
- Lung cancer4 trials
- Chronic kidney disease3 trials
- Endometrial cancer3 trials
- Head and neck cancer3 trials
- Pancreatic cancer3 trials
- Colorectal cancer2 trials
- Gastric and oesophageal cancer2 trials
- Heart failure2 trials
- Liver and biliary tract cancer2 trials
- and 16 more
- Phase
- Phase 321 trials
- Phase 27 trials
- Phase 13 trials
- Phase 1/23 trials
- Early phase 11 trial
- Phase 2/31 trial
- Status
- Recruiting14 trials
- Active, not recruiting12 trials
- Completed6 trials
- Not yet recruiting4 trials
- Terminated2 trials
- Withdrawn2 trials
- Lead sponsor
- Janssen Research & Development, LLC7 trials
- University of Sydney5 trials
- Amgen3 trials
- Australasian Gastro-Intestinal Trials Group3 trials
- Radiopharm Theranostics, Ltd2 trials
- and 19 more
Running trials
Not yet recruiting
Recruiting
Recruiting
Phase 3 Study to Assess Safety and Efficacy of 177Lu-TLX250 in Advanced Relapsed or Recurrent ccRCC
Recruiting
A Study of Terbium 161 (161Tb)-RAD402 in Participants With CRPC
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Talquetamab With Other Anticancer Therapies in Participants With Multiple Myeloma
Active, not recruiting
Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate
Recruiting
The Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis Study
Active, not recruiting
Nivolumab and Temozolomide Versus Temozolomide Alone in Newly Diagnosed Elderly Patients With GBM
Active, not recruiting
Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer
Active, not recruiting
Recruiting
Active, not recruiting
Trial of Preoperative Therapy for Gastric and Esophagogastric Junction Adenocarcinoma
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer2 recruiting
- Coronary artery disease2 recruiting
- Endometrial cancer2 recruiting
- Lung cancer2 recruiting
- Multiple myeloma2 recruiting
- Prostate cancer2 recruiting
- Amyloidosis1 recruiting
- Aortic stenosis1 recruiting
- Childhood cancers1 recruiting
- Dermatomyositis and polymyositis (myositis)1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Head and neck cancer1 recruiting
- Heart failure1 recruiting
- Hodgkin lymphoma1 recruiting
- Kidney cancer1 recruiting
- Melanoma1 recruiting
- Neuroendocrine tumours1 recruiting
- Pancreatic cancer1 recruiting
- Triple-negative breast cancer1 recruiting
- Ventricular tachycardia1 recruiting
Closed trials
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Terminated
Completed
Recruiting
A Study of Low-dose Intracoronary Thrombolytic Therapy in STEMI (Heart Attack) Patients.
Withdrawn
Completed
Treatment of Cardiovascular Disease With Low Dose Rivaroxaban in Advanced Chronic Kidney Disease
Terminated
Recruiting
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026